With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 20519118.
- Also identified by DOI 10.1016/j.cmet.2010.05.001 and PMC identifier 2885591.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Target of rapamycin (TOR) is an evolutionarily conserved nutrient-sensing protein kinase that regulates growth and metabolism in all eukaryotic cells. Studies in flies, worms, yeast, and mice support the notion that the TOR signaling network modulates aging. TOR is also emerging as a robust mediator of the protective effects of various forms of dietary restriction (DR), which can extend life span and slow the onset of certain age-related diseases across species. Here we discuss how modulating TOR signaling slows aging through downstream processes including mRNA translation, autophagy, endoplasmic reticulum (ER) stress signaling, stress responses, and metabolism. Identifying the mechanisms by which the TOR signaling network works as a pacemaker of aging is a major challenge and may help identify potential drug targets for age-related diseases, thereby facilitating healthful life span extension in humans.
Medical subject headings
- Aging
- Intracellular Signaling Peptides and Proteins
- Protein Serine-Threonine Kinases